Clik here to view.
Stratatech wins $4 million in defense funding for living skin substitute
Uncle Sam ponies up $4 million for Stratatech Corp.'s Phase IIb clinical trial of its StrataGraft living human skin substitute.Stratatech Corp. won $3.95 million from the U.S. Dept. of Defense's Armed...
View ArticleClik here to view.
First patient receives embryonic stem cells in spinal injury trial
The first patient to be injected with embryonic stem cells kicks off a clinical trial aimed at proving the treatment is safe for people with spinal cord injuries.Physicians injected the first-ever...
View ArticleClik here to view.
Athersys wins FDA nod for Phase II trial, posts wider Q3 losses
Athersys Inc. won Food & Drug Administration approval to begin a Phase II trial of its MultiStem stem cell treatmen for inflammatory bowel disease and posts wider third-quarter losses.Athersys Inc....
View ArticleClik here to view.
Feds blast Stryker Biotech, execs
Federal prosecutors blast back at a move by Stryker Corp.'s biotech subsidiary and several executives to have criminal charges dismissed in a federal case alleging the illegal promotion of bone...
View ArticleClik here to view.
BioDiogics and Predictive Biosciences ink licensing, distribution deals
BioDlogics licenses stem cell products to Amedica/US Spine; Predictive Biosciences licenses Epigenomics AG's prostate cancer biomarker.Amedica/US Spine and Predictive Biosciences announced licensing...
View ArticleClik here to view.
Dana-Farber researchers reverse aging in mice
Researchers at Boston's Dana-Farber Cancer Institute reverse the aging process in mice using a gene therapy technique.Researchers at Boston's Dana-Farber Cancer Institute managed to reverse brain...
View ArticleClik here to view.
Synovis tissue repair technology buoys sales for 2010
Synovis Life Technologies Inc. finishes 2010 with improved revenues, as the company beefs up its sales team and increases research and development spending.Synovis Life Technologies Inc. (NASDAQ:SYNO)...
View ArticleClik here to view.
Arteriocyte stem cell product mimics bone marrow
Arteriocyte Inc. launches a stem cell-based product called NANEX that allows researchers to grow red blood cells in a lab.Arteriocyte Inc. launched a stem cell-based product that allows researchers to...
View ArticleClik here to view.
Advanced Cell Technology CEO Caldwell dies
William Caldwell IV, chairman and CEO of Advanced Cell Technologies Inc., dies suddenly.William Caldwell IV, the chairman and CEO of Advanced Cell Technology Inc. (OTC:ACTC), died suddenly Dec. 13. He...
View ArticleBiotech founding father Eugene Goldwasser dies
Revolutionary biochemist opted for hospice care instead of dialysis, a procedure revolutionized by his research.By Merrill GooznerEugene Goldwasser, the University of Chicago biochemist whose...
View ArticleClik here to view.
UNC-Chapel Hill researchers close in on synthetic blood
A team of scientists at the University of North Carolina in Chapel Hill create particles with some of the properties of red blood cells.Synthetic blood is moving closer to becoming reality, thanks to...
View ArticleClik here to view.
Nuclea partners with Boston Medical on cancer biomarkers
Nuclea Biotechnologies Inc. and Boston Medical Center to collaborate on genetic research in breast and prostate cancer.Nuclea Biotechnologies Inc. is teaming up with Boston Medical Center to research...
View ArticleMedGadget's MedTech Monday: "Skin gun" sprays stems cells onto burn wounds
"Skin gun" sprays stems cells onto burn wounds; MIT suit simulates being 70; blind man takes Daytona; study: Medical clowns could improve chances for in vitro fertilization."Skin gun" sprays stems...
View ArticleClik here to view.
North Carolinian companies look hard for government incentives
Tar Heel biotech firms say they need incentives to compete with companies based in other states, but with a projected $3.7 billion budget shortfall, North Carolina might not be able to afford...
View ArticleClik here to view.
North Carolina biotech industry growing but R&D spending stays flat, E&Y...
Spending on biotech research and development isn't keeping pace with the growth in industry revenue in North Carolina, mirroring a nationwide trend.The North Carolina biotechnology industry is growing...
View ArticleClik here to view.
InVivo Therapeutics asks FDA for permission to run human trial
InVivo Therapeutics asks the FDA for an investigational device exemption to run a clinical trial of its biopolymer scaffold designed to treat traumatic spinal cord injuries.InVivo Therapeutics...
View ArticleClik here to view.
Will Baxter renew Medgenics drug pump deal?
Medgenics says it's negotiating with Baxter International over a newly expired deal to co-develop a drug pump, but Baxter is mum on the subject.Medgenics Inc. (NYSE:MDGN) said it's in talks with Baxter...
View ArticleClik here to view.
Kensey Nash wins $1.9M government grant | Funding Roundup
Kensey Nash Corp. lands a $1.9 million grant from the National Institutes of Health to investigate the use of surgical mesh for tendon repair.Kensey Nash Corp. (NSDQ:KNSY) landed a small business...
View ArticleClik here to view.
Feds drop charges against former Stryker Biotech rep
Federal prosecutors drop all charges against 1 of the former Stryker Biotech sales reps accused of off-label promotion.Federal prosecutors dropped all charges against 1 of the former Stryker Biotech...
View ArticleClik here to view.
Diabetes: Intarcia pulls down $210M for drug-device combo| Wall Street Beat
Intarcia Therapeutics closes a pair of funding rounds worth a total of $210 million for its drug-device combination treatment for Type II diabetesIntarcia Therapeutics said it's reeled in financing...
View Article